Modeling microRNA-mRNA interactions using PLS regression in human colon cancer

Xiaohong Li1, Ryan Gill, Nigel G F Cooper

  • 1Department of Bioinformatics and Biostatistics, University of Louisville, Louisville, KY 40202, USA.

Abstract

Insights

This study introduces a novel bioinformatics method to identify microRNA (miRNA) targets and construct miRNA:mRNA networks in human colon cancer, offering new insights into cancer mechanisms.

Area of Science:

  • Bioinformatics
  • Genomics
  • Cancer Research

Background:

  • MicroRNA (miRNA) expression changes are known in colon cancer, but their specific roles and mRNA targets remain unclear.
  • Understanding these molecular mechanisms is crucial for advancing colon cancer etiology research.

Purpose of the Study:

  • To develop and validate a bioinformatics approach for identifying miRNA targets in human colon cancer.
  • To construct miRNA:mRNA association networks to elucidate underlying molecular mechanisms.
  • To identify novel therapeutic targets for colon cancer.

Main Methods:

  • Utilized microarray expression profiles of miRNA and mRNA from human colon tumor and normal tissues.
  • Applied partial least square (PLS) regression and bootstrap tests to identify associations between differentially expressed miRNAs and mRNAs.
  • Employed pathway analysis to identify biological processes involving predicted miRNA targets.

Main Results:

  • Identified putative miRNA targets by analyzing inversely correlated miRNA and mRNA expression profiles.
  • The proposed method predicted more targets than common algorithms like TargetScan and miRanda.
  • Constructed integrative mRNA:miRNA networks and validated miRNAs involved in cancer-associated biological networks.

Conclusions:

  • An alternative bioinformatics approach for predicting miRNA targets and reverse engineering miRNA:mRNA networks in colon cancer was established.
  • The predictive method demonstrated superiority over correlation-based approaches.
  • Predicted unique miRNA targets may advance the understanding of colon cancer molecular mechanisms and suggest novel therapeutic strategies.